facebook app symbol  twitter  instagram 1

Mobile Ad Container

Raven Indigenous Capital Partners said it invested $3.2 million in Tribal Diagnostics LLC, an Oklahoma City-based medical diagnostics laboratory serving medical providers in and around Indian Country. 

The investment will help the medical firm expand into new markets and hire additional staff, according to a statement. Tribal Diagnostics is led by its founder and CEO Corey Littlepage (Chickasaw), a former Pfizer executive who also worked in the private equity industry.  

Founded in 2015, Tribal Diagnostics partners with over a thousand providers across 10 States, including about two dozen Indian Health Service, tribal and urban facilities.  The company is owned and operated by Native Americans.  

Never miss the biggest stories and breaking news about the tribal economy. Sign up to get our reporting sent straight to your inbox every Monday morning.

The investment is the latest by Vancouver-based Raven, which raised $75 million earlier this year to support its second venture fund, which is focused on early- and growth-stage companies led by Indigenous entrepreneurs in Canada and the U.S. 

In an interview with Tribal Business News earlier this year, the firm’s U.S. lead said the new fund was most interested in companies in the technology, clean energy/renewables, health, and regenerative agriculture industries. 

In a statement issued today, Raven said it plans to invest more than $30 million into Native American, Alaska Native and Native Hawaiian-owned businesses over the next three years.